Matinas BioPharma
MTNB
#10153
Rank
A$4.24 M
Marketcap
$0.83
Share price
-4.57%
Change (1 day)
-94.38%
Change (1 year)

Earnings for Matinas BioPharma (MTNB)

Earnings in 2024 (TTM): -A$31.47 Million

According to Matinas BioPharma's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$36.8 Million a decrease over its 2022 earnings that were of -A$33.68 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Matinas BioPharma from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$31.47 Million-14.49%
2023 -A$36.8 Million9.26%
2022 -A$33.68 Million-9.82%
2021 -A$37.35 Million3.73%
2020 -A$36.01 Million29.21%
2019 -A$27.87 Million19.07%
2018 -A$23.4 Million-7.91%
2017 -A$25.41 Million108.5%
2016 -A$12.19 Million-16.82%
2015 -A$14.66 Million-10.62%
2014 -A$16.4 Million175.27%
2013 -A$5.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.22 Billion 537.67%๐Ÿ‡บ๐Ÿ‡ธ USA